Table 3.
Percentage of eyes with residual intraretinal fluid within the macula, including only patients still under treatment. The p values for group comparisons are annotated after the values of group 2
| Group 1: 2007–2012 | Group 2: 2013–2017 | |||||||
|---|---|---|---|---|---|---|---|---|
| Residual intraretinal fluid (%) | Number of visits (mean ± SD) | Number of injections (mean ± SD) | Residual intraretinal fluid (%) | Number of visits (mean ± SD) | Number of injections (mean ± SD) | |||
| 1 year | n = 63 | 81.4 | 6.6 ± 3.3 | 3.6 ± 2.7 | n = 88 |
81.8 (p = 1.0) |
7.5 ± 2.1 (p = 0.007) |
6.1 ± 2.7 (p = 2.11e-08) |
| 2 years | n = 63 | 74.2 | 6.0 ± 3.3 | 1.6 ± 1.7 | n = 88 |
87.2 (p = 0.053) |
5.4 ± 2.3 (p = 0.13) |
3.4 ± 2.7 (p = 3.94e-05) |
| 3 years | n = 57 | 75.9 | 5.2 ± 3.0 | 1.8 ± 1.7 | n = 65 |
75.0 (p = 1.0) |
4.8 ± 2.1 (p = 0.77) |
2.9 ± 2.8 (p = 0.09) |
| 4 years | n = 57 | 70.8 | 5.5 ± 3.3 | 1.4 ± 1.9 | n = 52 |
76.1 (p = 0.64) |
4.5 ± 1.9 (p = 0.30) |
2.6 ± 2.7 (p = 0.039) |
| 5 years | n = 53 | 68.0 | 5.1 ± 3.4 | 1.6 ± 1.8 | n = 31 |
77.4 (p = 0.45) |
4.8 ± 2.1 (p = 0.86) |
3.6 ± 3.7 (p = 0.028) |
p values for group comparisons are annotated after the values of group 2. Significant group comparisons are highlighted in bold
SD standard deviation